Our Services
Medical Information
Helpful Resources
Published on: 3/12/2026
Precision medicine in psychiatry personalizes depression treatment using pharmacogenomic testing, careful symptom profiling, targeted labs for inflammation and nutrient deficiencies, and, when appropriate, options like TMS, ketamine or esketamine, always combined with evidence based therapy and lifestyle changes.
Next steps often include reassessing the diagnosis, confirming adequate medication trials, considering genetic testing, screening for medical contributors, and discussing advanced treatments, with urgent care for any suicidal thoughts. There are several factors to consider; see below for the detailed roadmap, key caveats, and safety guidance that could change which steps are right for you.
If you're still feeling depressed despite trying treatment, you are not alone. Many people with depression do not fully respond to the first medication or therapy they try. This can feel discouraging. But medicine is evolving. One of the most promising advances is precision medicine for psychiatry.
Instead of using a "trial-and-error" approach, precision medicine aims to tailor treatment to you — your biology, your symptoms, your history, and even your genes.
Let's break down precision medicine for psychiatry — how it works, what new medical steps are involved, and what you can realistically expect.
Depression is not one single disease. It is a complex condition influenced by:
Most antidepressants were developed based on broad theories about serotonin, norepinephrine, and dopamine. While they help many people, they don't work for everyone. In fact:
This is where precision medicine offers a new direction.
Precision medicine for psychiatry is an approach that uses biological, genetic, and clinical data to guide treatment decisions. Instead of guessing which medication might work, doctors use measurable information to better match treatments to the individual.
In simple terms:
The right treatment, for the right person, at the right time.
This approach is based on research from genetics, neuroscience, pharmacology, and data science.
Precision psychiatry focuses on identifying patterns that predict how someone will respond to a treatment.
Here are the key tools being used:
Pharmacogenomic testing looks at how your genes affect the way your body processes medications.
Some people metabolize antidepressants:
These tests often examine liver enzymes such as CYP2D6 and CYP2C19.
Important points:
Many psychiatrists now use this testing when someone has not responded to multiple medications.
Depression symptoms vary widely. Some people experience:
Different symptom patterns may respond better to different treatments. For example:
A detailed symptom review helps guide medication choice more precisely.
If you're unsure whether your symptoms align with clinical depression, you can use this free AI-powered Depression symptom checker to get personalized insights before your next doctor's appointment.
Emerging research shows that some people with depression have elevated inflammatory markers.
In certain cases, doctors may check:
Treating underlying deficiencies or medical contributors can significantly improve mood.
Depression is sometimes worsened by:
Precision medicine looks beyond the brain alone.
While not yet routine, researchers are studying how brain scans may help predict treatment response. Patterns of brain activity may eventually guide:
This area is still developing but shows promise.
Precision medicine has also expanded available treatment options.
Doctors may combine medications in targeted ways, such as:
These are carefully selected based on symptom pattern and history.
It's important to stay grounded.
Precision medicine:
It improves probabilities — it does not promise certainty.
Even with advanced tools, medication alone is rarely enough.
Strong evidence supports:
Precision medicine works best when combined with these foundational steps.
If you're not improving, here is a practical roadmap:
Misdiagnosis can delay effective treatment.
Ask your psychiatrist if genetic testing may help guide next steps.
Request basic labs if not already done.
If two or more medications have failed, talk about:
Sleep, movement, alcohol, and stress matter more than most people realize.
If you are experiencing:
This is urgent. Speak to a doctor immediately or seek emergency care. Depression can become life-threatening, and rapid treatment is available.
Do not try to handle severe symptoms alone.
Precision medicine for psychiatry — how it works — is about moving beyond guesswork. It combines genetics, biology, symptom patterns, and advanced therapies to improve your chances of recovery.
If you're still depressed:
Modern psychiatry now offers more tools than ever before. The key is careful reassessment, individualized planning, and open communication with your doctor.
Before your next appointment, consider taking a free AI-powered Depression symptom checker to help you clearly communicate what you're experiencing and get a better understanding of your symptoms.
Most importantly, speak to a qualified healthcare professional about your symptoms — especially if they are severe, worsening, or life-threatening.
Depression is real. It can be persistent. But it is treatable — and treatment is becoming more personalized every year.
(References)
* Kautzky A, Kopeinig M, Ringer C, Wozniak E, Wager T, Lanzenberger R. Precision Psychiatry: A New Way Forward for Patients with Major Depressive Disorder. Transl Psychiatry. 2023 Jun 23;13(1):210. doi: 10.1038/s41398-023-02506-6. PMID: 37353406.
* Greden JF, Parikh SV, Lipkovich I, Dunner DL, DeBattista C, Hassel S, Rush AJ, Trivedi MH, Fava M. Pharmacogenomic Testing for Depression: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2019 Aug 1;76(8):850-862. doi: 10.1001/jamapsychiatry.2019.0494. PMID: 31215967.
* Kapur S, Phillips AG, Insel TR. Precision Psychiatry: The Road to Personalized Mental Health Care. Biol Psychiatry. 2021 Jul 15;90(2):83-91. doi: 10.1016/j.biopsych.2021.05.004. PMID: 34024357.
* Llopis N, Olmos P, Blay S, Montaner E, Garcia-Rizo C, Mezquida G, Fernández-Corcuera JM, Amoretti S, Alomar C, Usall J, BioPsich-Banc. Biomarkers in major depressive disorder: a state-of-the-art review. Mol Psychiatry. 2023 Sep;28(9):3771-3788. doi: 10.1038/s41380-023-02199-z. PMID: 37495861.
* Trivedi MH, Daly E, Nemeroff CB. The Future of Depression: Precision Medicine, AI, and Novel Therapies. Mol Psychiatry. 2023 Aug;28(8):3109-3112. doi: 10.1038/s41380-023-02206-3. PMID: 37518424.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.